DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Status of Application
Claims 1, 3-5 and 13 (2 and 6-12 withdrawn) are pending and presented for examination. Claim 1 was amended and claim 13 newly added via the instant amendment dated 30 September 2026 which is acknowledged and entered.
Response to Arguments
Applicant’s remarks dated 30 September 2026 (hereinafter, “Remarks at __”) are acknowledged and entered.
The rejection of claims 1, 4 and 5 under 35 U.S.C. 102(a)(1) over Hashimoto is MAINTAINED and updated below to reflect the instant amendment.
The traversal is that Hashimoto discloses neodecanoic acid, which is a branched atty acid having 10 carbon atoms as the claim requires that there be at least 12 carbon atoms in the branched fatty acid (Remarks at 6). This is persuasive. However, “Example 5” of Hashimoto adds stearic acid which is linear saturated fatty acid having 18 carbon atoms, and as such decanoic acid (capping agent) and stearic acid (which is also a capping agent) are both present in the solution along with toluene. However, the rejection of claim 3 is WITHDRAWN as no surfactant is in Example 5.
The rejection of claims 1 and 3-5 under 35 U.S.C. 102(a)(1) over Matsumoto is WITHDRAWN over the instant amendment limiting the carboxylic acid as CA1 and CA2 in Matsumoto do not fit the species claimed.
Claim Objections
Claim 1 is objected to because of the following informalities: “wherein the carboxylic acid” should read --wherein the carboxylic acid having 9 or more carbon atoms--. Appropriate correction is required.
Claim Rejections - 35 USC § 112
The following is a quotation of the first paragraph of 35 U.S.C. 112(a):
(a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention.
The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112:
The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.
Claims 1, 3-5 and 13 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. There is insufficient support in the specification for “a branched fatty acid having 12 or more carbon atoms”, while the specification states “9 or more”, this does not show possession of all branched fatty acids over 12 (i.e., mycolic acid) as the upper limit is given later as 35 (with 10 to 24 most preferred). This is a new matter rejection.
Claim Rejections - 35 USC § 102
The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action.
Claims 1, 4, 5 and 13 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Hashimoto.
Regarding claims 1, 5 and 13 Hashimoto discloses a metal oxide dispersion (Hashimoto at “Example 5”) comprising:
A carboxylic acid, stearic acid, which is a linear saturated fatty acid with 18 carbon atoms (Id.);
A metal oxide, zirconium oxide, capped with neodecanoic acid (Id.); and
A solvent (toluene, Id.).
Concerning claim 4, 1.5g of organic is added to 10g of zirconia so 10/11.5=86.7%.
Claims 1 and 13 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US PG Pub No. 20210163311 to Bansal et al. (hereinafter, “Bansal at __”).
Regarding claims 1 and 13, Bansal discloses a metal oxide dispersion (Bansal at “Abstract”) comprising:
A carboxylic acid, oleic acid, which is a linear saturated carboxylic acid having 18 carbon atoms (Bansal at [0037]);
A metal oxide (iron oxide, [0010]) nanoparticle surface-treated with a capping agent (tertiary amines); and a solvent of water ([0014]).
Claims 1, 3, 5 and 13 are rejected under 35 U.S.C. 103 as being unpatentable over “A general and facile approach to disperse hydrophobic nanocrystals in water with enhanced long-term stability” to Wu et al. (hereinafter, “Wu at __”).
Regarding claims 1, 3, 5 and 13, Wu discloses a metal oxide dispersion (Wu at “Abstract”) comprising:
A carboxylic acid, oleic acid, which is a saturated linear carboxylic fatty acid having 18 carbon atoms;
Metal oxide nanoparticles capped with oleic acid, oleylamine, or TOPO (“Fig. 2”, “Fig. 3”, or “Fig. 4” for iron oxide, gold, and titania; 1066 L col, see also the “Supporting Information” of Wu);
A solvent (sodium oleate solution, Id., wherein sodium oleate is a surfactant for claim 3).
Conclusion
Claims 1, 3-5 and 13 are finally rejected.
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to RICHARD M RUMP whose telephone number is (571)270-5848. The examiner can normally be reached Monday-Thursday 06:45 AM to 04:45 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Curtis Mayes can be reached at 571-272-1234. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
RICHARD M. RUMP
Primary Examiner
Art Unit 1759
/RICHARD M RUMP/ Primary Examiner, Art Unit 1759